Sanofi has signed an agreement to acquire UK-based biotechnology company Vicebio’s share capital for $1.15bn upfront, to expand its vaccine development capabilities. The deal also includes additional ...

French pharmaceutical and healthcare company Sanofi has agreed to buy the British biotechnology firm Vicebio for up to $1.6bn ...

Paris-based drugmaker Sanofi is acquiring U,K,-based Vicebio to gain its molecular clamp vaccine technology, with the total ...

Respiratory vaccines specialist Vicebio Ltd. is to be acquired by Sanofi SA in a $1.6 billion deal, of which $1.15 billion ...

Health care companies recouped some of their recent losses amid generally strong earnings and deal activity. British drug maker AstraZeneca said it plans to invest $50 billion in the U.S. by 2030, ...

It’s not a love-in yet and Hutchies boss Scott Hutchinson still reckons unions are “a pain in the ass” but relations are improving with just seven years to go before the opening ceremony of the 2032 ...

A UK company developing technology spun out of the University of Queensland is poised for growth after being acquired by ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. A visit to the chiropractor can provide many health benefits.

The US Securities and Exchange Commission has subpoenaed information from Telix, in relation to the company's therapeutic ...

Sanofi’s $1.76 billion acquisition of Vicebio delivers a windfall for the University of Queensland — and highlighted a ...

Sanofi acquires UQ-linked biotech Vicebio for up to US$1.6b, marking Australia’s largest university commercialisation deal.

Sussan Ley’s first big moment in parliament as Liberal leader was overshadowed by Coalition infighting, with Nationals MPs ...